Rituximab Maintenance for Patients With Diffuse Large B-Cell Lymphoma in First Complete Remission: Results From a Randomized HOVON-Nordic Lymphoma Group Phase III Study

被引：0
|
作者：
不详
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2019年 / 17卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6 / 8
页数：3
相关论文
共 50 条
  • [1] Rituximab maintenance for patients with diffuse large B-cell lymphoma in first complete remission: Results from a randomized HOVON-Nordic Lymphoma Group phase III study.
    Lugtenburg, Elly J.
    Brown, Peter
    van der Holt, Bronno
    D'Amore, Francesco
    Koene, Harry R.
    de Jongh, Eva
    Fijnheer, Rob
    Loosveld, Olaf
    Bohmer, Lara H.
    Pruijt, Hans
    Verhoef, Gregor
    Hoogendoorn, Mels
    Bilgin, Yavuz
    Nijland, Marcel
    Lam, King H.
    de Keizer, Bart
    de Jong, Daphne
    Zijlstra, Josee M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] RANDOMIZED PHASE III STUDY OF EARLY RITUXIMAB INTENSIFICATION IN COMBINATION WITH CHOP14 FOLLOWED BY RITUXIMAB OR NO MAINTENANCE IN DIFFUSE LARGE B-CELL LYMPHOMA: A HOVON-NORDIC LYMPHOMA GROUP STUDY
    Lugtenburg, P.
    Brown, P. de Nully
    van der Holt, B.
    d'Amore, F.
    Koene, H.
    Berenschot, H.
    Fijnheer, R.
    Loosveld, O.
    Bohmer, L.
    Pruijt, J.
    Verhoef, G.
    Hoogendoorn, M.
    de Kan, R.
    van Imhoff, G.
    van Hooije, C.
    Lam, K.
    de Keizer, B.
    de Jong, D.
    Hoekstra, O.
    Zijlstra, J.
    HAEMATOLOGICA, 2016, 101 : 173 - 173
  • [3] Rituximab maintenance for patients with diffuse large B-cell lymphoma in first complete remission: Long-term results of the HOVON-84 randomized phase III study by the HOVON and the Nordic Lymphoma Group (clinical trial number: NTR1014)
    Lugtenburg, Pieternella Johanna
    Brown, Peter de Nully
    van der Hol, Bronno
    de Jongh, Eva
    Zijlstra, Josee M.
    EUROPEAN JOURNAL OF CANCER, 2025, 214
  • [4] Randomized phase III study on the effect of early intensification of rituximab in combination with 2-weekly CHOP chemotherapy followed by rituximab or no maintenance in patients with diffuse large B-cell lymphoma: Results from a HOVON-Nordic Lymphoma Group study.
    Lugtenburg, Pieternella J.
    Brown, Peter de Nully
    van der Holt, Bronno
    D'Amore, Francesco
    Koene, Harry R.
    Berenschot, Henriette W.
    Fijnheer, Rob
    Loosveld, Olaf
    Bohmer, Lara H.
    Pruijt, Hans
    Verhoef, Gregor
    Hoogendoorn, Mels
    de Kan, Romko
    Van Imhoff, Gustaaf Willem
    van Hooije, Christel
    Lam, King H.
    de Keizer, Bart
    de Jong, Daphne
    Hoekstra, Otto S.
    Zijlstra, Josee M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84)
    Lugtenburg, Pieternella Johanna
    Brown, Peter de Nully
    van der Holt, Bronno
    D'Amore, Francesco A.
    Koene, Harry R.
    de Jongh, Eva
    Fijnheer, Rob
    van Esser, Joost W.
    Boehmer, Lara H.
    Pruijt, Johannes F.
    Verhoef, Gregor E.
    Hoogendoorn, Mels
    Bilgin, Memis Y.
    Nijland, Marcel
    van der Burg-de Graauw, Nicole C.
    Oosterveld, Margreet
    Jie, Kon-Siong G.
    Larsen, Thomas Stauffer
    van der Poel, Marjolein W.
    Leijs, Maria B.
    Silbermann, Matthijs H.
    Kooy, Marinus van Marwijk
    Beeker, Aart
    Kersten, Marie J.
    Doorduijn, Jeanette K.
    Tick, Lidwine W.
    Brouwer, Rolf E.
    Lam, King H.
    Burggraaff, Coreline N.
    de Keizer, Bart
    Arens, Anne I.
    de Jong, Daphne
    Hoekstra, Otto S.
    Zijlstra-Baalbergen, Josee M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29) : 3377 - 3387
  • [6] Nivolumab Maintenance in First Complete Remission of Diffuse Large B-Cell Lymphoma
    Kedmi, Meirav
    Ribakovsky, Elena
    Benjamini, Ohad
    Shimoni, Avichai
    Avigdor, Abraham
    BLOOD, 2022, 140 : 12071 - 12072
  • [7] Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial
    Fjorden, Karin
    Ekberg, Sara
    Kuric, Nevzeta
    Smedby, Karin E.
    Lagerlof, Ingemar
    Larsen, Thomas S.
    Jorgensen, Judit M.
    de Nully Brown, Peter
    Jerkeman, Mats
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (02) : 437 - 440
  • [8] Rituximab maintenance therapy in diffuse large B-cell lymphoma
    Trajkova, S.
    Panovska-Stavridis, I.
    Stojanovik, A.
    Dukovski, D.
    Cevreska, L.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 : S22 - S23
  • [9] Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial
    Jaeger, Ulrich
    Trneny, Marek
    Melzer, Helen
    Praxmarer, Michael
    Nawarawong, Weerasak
    Ben Yehuda, Dina
    Goldstein, David
    Mihaljevic, Bilijana
    Ilhan, Osman
    Ballova, Veronika
    Hedenus, Michael
    Hsiao, Liang-Tsai
    Au, Wing-Yan
    Burgstaller, Sonja
    Weidinger, Gerhard
    Keil, Felix
    Dittrich, Christian
    Skrabs, Cathrin
    Klingler, Anton
    Chott, Andreas
    Fridrik, Michael A.
    Greil, Richard
    HAEMATOLOGICA, 2015, 100 (07) : 955 - 963
  • [10] Comment on "Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial"
    Vassilakopoulos, Theodoros P.
    Apostolidis, John
    Angelopoulou, Maria K.
    HAEMATOLOGICA, 2015, 100 (11) : E480 - E481
12345